Renzenbrink & Partner advises Bruker Corporation on the acquisition of JPK Instruments AG

Renzenbrink & Partner has advised Bruker Corporation on the acquisition of JPK Instruments AG, a leading manufacturer of nanoanalytical instruments based in Berlin. JPK’s products enable biomolecular and cellular imaging as well as force measurements on individual molecules, cells and body tissue.

With sales of nearly $2 billion and more than 6,000 employees worldwide, NASDAQ-listed Bruker Corporation is a global manufacturer of high-end analytical instruments used in science & research, pharmaceutical/biotechnology, clinical diagnostics and industry. The company operates in the Life Science Tools & Diagnostics sector and has built a reputation for innovation and quality. JPK’s products and expertise in life science applications will allow Bruker to leverage synergies with its existing portfolio of advanced fluorescence microscopy products
.

Renzenbrink & Partner advised Bruker Corporation comprehensively on all legal aspects of the transaction.

The Renzenbrink & Partner team consisted of partners Dr. Andreas Stoll (M&A/Corporate), Marc H. Kotyrba (Tax) and Dr. Gunnar Schmüser (Finance) as well as associates Dr. Alexander Haunschild, Dr. Niels Maier and Dr. Florian Seitz.

For employment law aspects, Renzenbrink & Partner worked together with Dr. Holger Meyer and Sophie Kuske from the law firm Schramm Meyer Kuhnke. Dr. Kai-Uwe Plath and Dr. Jan-Michael Grages from the law firm KNPZ assisted in the area of IP law. Dr. Andreas Hahn from the law firm Oppenländer advised on competition law aspects.